A federal judge tossed out a securities class action against Marietta, Georgia-based biotech firm MiMedx, two former executives and an accounting firm, ruling that the lead plaintiff could not show that revelations about the company’s inflated revenue claims caused its shares’ value to plummet before they were sold. 

The ruling comes more than a month after former CEO Parker “Pete” Petit, 81, and former chief operations officer William Taylor were each sentenced to a year in federal prison after being found guilty of accounting fraud following a four-week trial in New York.  

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]